Glooko Names Kyle Brown as Chief Technology Officer
Transformative Healthcare Technology Entrepreneur joins leader in diabetes data management
MOUNTAIN VIEW, Calif., April 9, 2020 — As part of its continued focus on delivering data enabled solutions to improve the lives of people with diabetes, Glooko, the leader in diabetes digital health, data management solutions and remote monitoring solutions, today announced the appointment of Kyle Brown as Chief Technology Officer.
Brown joins Glooko with an extensive executive background in digital health, where he has successfully built several technology companies focused on the shift from clinician-entered proprietary registries to open and inclusive Patient Insight Networks.
“We’re very excited to have Kyle joining our company at this important time in our development. His extensive experience building data-driven healthcare technology businesses, together with his unique background in software development, patient advocacy, and support of clinical research, will be incredibly valuable for Glooko as we continue to grow” said Russ Johannesson, CEO of Glooko.
In his new role with Glooko, Brown will have global responsibility for all technology and engineering efforts.
“Glooko’s work enhancing the patient-clinician relationship, especially in these times of accelerating adoption of remote care and telemedicine technologies, is a perfect match with my passion for leveraging the digital content to improve patient care,” Brown said. “I am very excited to be a part of the company’s global expansion to create new ways to better engage people with diabetes”.
Brown comes to Glooko from PatientCrossroads/AltaVoice, which he founded and led for over a decade. The company’s mission was to harness the collective knowledge of patient communities to drive faster treatments while creating a market for patient provided data. As CEO, Brown led the implementation of over 125 patient registry programs collecting data on more than 400 diseases in collaboration with advocacy, academia, government and pharmaceutical companies.
Glooko’s universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. The Glooko product suite contains the Glooko and diasend® diabetes management solutions, which integrate with many of the leading EHR systems used today. Both systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake. Trusted by the world’s leaders in diabetes care, our solutions cover more than 2.8 million people with diabetes and are used in 9,000+ clinic locations in 25 countries across 15 languages. Learn more by visiting www.glooko.com
For inquiries, please email PR@Glooko.com.